Dominik Andreas Barth (Dominik A Barth, D A Barth)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 14

Top Topics

Renal Cell Carcinoma

Tyrosine Kinase

Long Noncoding Rna

Prognostic Factors

Top Venues

Cancer medicine

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, Michael Stidl, Tobias Niedrist, Renate Pichler, Johannes Mischinger, Maximilian Seles, Sebastian Mannweiler, Jasmin Spiegelberg, Thomas Bauernhofer, Philipp J Jost, Sascha Ahyai, Richard Zigeuner, Martin Pichler, Dominik Andreas Barth
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up. Therapeutic advances in medical oncology 14 (2022)
Dominik Andreas Barth, Stefanie Stanzer, Jasmin Spiegelberg, Thomas Bauernhofer, Gudrun Absenger, Florian Posch, Rainer Lipp, Michael Halm, Joanna Szkandera, Marija Balic, Armin Gerger, Maria A Smolle, Georg C Hutterer, Christiane Klec, Philipp J Jost, Julia Kargl, Martin Stradner, Martin Pichler
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study. Cancer medicine 11 (16) (2022)
Florian Posch, Felix Prinz, Amar Balihodzic, Christian Mayr, Tobias Kiesslich, Christiane Klec, Katharina Jonas, Dominik Andreas Barth, Jakob M Riedl, Armin Gerger, Martin Pichler
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms. Cancers 13 (16) (2021)
Amar Balihodzic, Dominik Andreas Barth, Felix Prinz, Martin Pichler
Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer. Cancers 13 (5) (2021)
Jakob Michael Riedl, Dominik Andreas Barth, Wolfgang M Brückl, Gloria Zeitler, Vasile Foris, Stefanie Mollnar, Michael Stotz, Christopher H Rossmann, Angelika Terbuch, Marija Balić, Tobias Niedrist, Thomas Bertsch, Herbert Stoeger, Martin Pichler, Horst Olschewski, Gudrun Absenger, Joachim H Ficker, Armin Gerger, Florian Posch
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study. Cancers 12 (8) (2020)
Dominik Andreas Barth, Jaroslav Juracek, Ondrej Slaby, Martin Pichler, George A Calin
lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System. Cancers 12 (8) (2020)
Dominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, Felix Prinz, Eva Valentina Klocker, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Herbert Stöger, Michael Stotz, Armin Gerger, Martin Pichler
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients. Cancer medicine 9 (15) (2020)
Dominik Andreas Barth, Felix Prinz, Julia Teppan, Katharina Jonas, Christiane Klec, Martin Pichler
Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer. Non-coding RNA 6 (3) (2020)
Michael Stotz, Dominik Andreas Barth, Jakob Michael Riedl, Eva Asamer, Eva V Klocker, Peter Kornprat, Georg C Hutterer, Felix Prinz, Karoline Lackner, Herbert Stöger, Armin Gerger, Martin Pichler
The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer. Cancers 12 (7) (2020)
Julia Teppan, Dominik Andreas Barth, Felix Prinz, Katharina Jonas, Martin Pichler, Christiane Klec
Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis. Non-coding RNA 6 (4) (2020)
Anna L Lembeck, Philip Puchas, Georg Hutterer, Dominik Andreas Barth, Angelika Terbuch, Thomas Bauernhofer, Martin Pichler
MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients. Non-coding RNA 6 (1) (2020)
Eva Valentina Klocker, Dominik Andreas Barth, Jakob Michael Riedl, Felix Prinz, Joanna Szkandera, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Joerg Lindenmann, Herbert Stöger, Michael Stotz, Armin Gerger, Martin Pichler
Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients. Cancers 12 (5) (2020)
Dominik Andreas Barth, Ondrej Slaby, Christiane Klec, Jaroslav Juracek, Rares Drula, George A Calin, Martin Pichler
Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. Cancers 11 (10) (2019)
Dominik Andreas Barth, J M Riedl, F Posch, M A Smolle, A-K Kasparek, T Niedrist, J Szkandera, H Stöger, M Pichler, M Stotz, A Gerger
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (8) (2019)